«Iron deficiency in sports – definition, influence on performance and therapy». Swiss Med Wkly (Review) 145: w14196. 2015. PMID26512429. doi:10.4414/smw.2015.14196.
Geisser P (2007). «Safety and efficacy of iron(III)-hydroxide polymaltose complex / a review of over 25 years experience». Arzneimittelforschung57 (6A): 439-52. PMID17691594. doi:10.1055/s-0031-1296693.
«Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis». Arzneimittelforschung57 (6A): 431-8. 2007. PMID17691593. doi:10.1055/s-0031-1296692.
Oppenheimer, Stephen J. (2001). «Iron and its Relation to Immunity and Infectious Disease». The Journal of Nutrition131 (2): 616S-635S. PMID11160594. doi:10.1093/jn/131.2.616S.
Hershko, C.; Ianculovich, M.; Souroujon, M. (2007). «Decreased Treatment Failure Rates following Duodenal Release Ferrous Glycine Sulfate in Iron Deficiency Anemia Associated with Autoimmune Gastritis and Helicobacter pylori Gastritis». Acta Haematologica118 (1): 19-26. PMID17426393. doi:10.1159/000101701.
Ponikowski, Piotr; Voors, Adriaan A.; Anker, Stefan D.; Bueno, Héctor; Cleland, John G. F.; Coats, Andrew J. S.; Falk, Volkmar; González-Juanatey, José Ramón et al. (2016). «2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure». European Heart Journal37 (27): 2129-2200. PMID27206819. doi:10.1093/eurheartj/ehw128.Se sugiere usar |número-autores= (ayuda)
Dignass, Axel U.; Gasche, Christoph; Bettenworth, Dominik; Birgegård, Gunnar; Danese, Silvio; Gisbert, Javier P.; Gomollon, Fernando; Iqbal, Tariq et al. (2015). «European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases». Journal of Crohn's and Colitis9 (3): 211-222. PMID25518052. doi:10.1093/ecco-jcc/jju009.Se sugiere usar |número-autores= (ayuda)
Chertow, Glenn M.; Mason, Phillip D.; Vaage-Nilsen, Odd; Ahlmén, Jarl (2004). «On the relative safety of parenteral iron formulations». Nephrology Dialysis Transplantation19 (6): 1571-5. PMID15150356. doi:10.1093/ndt/gfh185.
Jahn, Markus R.; Andreasen, Hans B.; Fütterer, Sören; Nawroth, Thomas; Schünemann, Volker; Kolb, Ute; Hofmeister, Wolfgang; Muñoz, Manuel et al. (2011). «A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications». European Journal of Pharmaceutics and Biopharmaceutics78 (3): 480-91. PMID21439379. doi:10.1016/j.ejpb.2011.03.016.Se sugiere usar |número-autores= (ayuda)
drugs.com
«Iron Preparations, Oral». The American Society of Health-System Pharmacists. Archivado desde el original el 22 de mayo de 2016. Consultado el 8 de enero de 2017.
«Iron deficiency in sports – definition, influence on performance and therapy». Swiss Med Wkly (Review) 145: w14196. 2015. PMID26512429. doi:10.4414/smw.2015.14196.
Geisser P (2007). «Safety and efficacy of iron(III)-hydroxide polymaltose complex / a review of over 25 years experience». Arzneimittelforschung57 (6A): 439-52. PMID17691594. doi:10.1055/s-0031-1296693.
«Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis». Arzneimittelforschung57 (6A): 431-8. 2007. PMID17691593. doi:10.1055/s-0031-1296692.
«Relative effectiveness of iron bis-glycinate chelate (Ferrochel) and ferrous sulfate in the control of iron deficiency in pregnant women». Arch Latinoam Nutr51 (1 Suppl 1): 42-7. 2001. PMID11688081.
Ashmead SD (2001). «The chemistry of ferrous bis-glycinate chelate». Arch Latinoam Nutr51 (1 Suppl 1): 7-12. PMID11688084.
Oppenheimer, Stephen J. (2001). «Iron and its Relation to Immunity and Infectious Disease». The Journal of Nutrition131 (2): 616S-635S. PMID11160594. doi:10.1093/jn/131.2.616S.
Aronstam, A.; Aston, D. (1982). «A comparative trial of a controlled-release iron tablet preparation ('Ferrocontin' Continus) and ferrous fumarate tablets». Pharmatherapeutica3 (4): 263-267. PMID7146040.
Hershko, C.; Ianculovich, M.; Souroujon, M. (2007). «Decreased Treatment Failure Rates following Duodenal Release Ferrous Glycine Sulfate in Iron Deficiency Anemia Associated with Autoimmune Gastritis and Helicobacter pylori Gastritis». Acta Haematologica118 (1): 19-26. PMID17426393. doi:10.1159/000101701.
Ponikowski, Piotr; Voors, Adriaan A.; Anker, Stefan D.; Bueno, Héctor; Cleland, John G. F.; Coats, Andrew J. S.; Falk, Volkmar; González-Juanatey, José Ramón et al. (2016). «2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure». European Heart Journal37 (27): 2129-2200. PMID27206819. doi:10.1093/eurheartj/ehw128.Se sugiere usar |número-autores= (ayuda)
Dignass, Axel U.; Gasche, Christoph; Bettenworth, Dominik; Birgegård, Gunnar; Danese, Silvio; Gisbert, Javier P.; Gomollon, Fernando; Iqbal, Tariq et al. (2015). «European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases». Journal of Crohn's and Colitis9 (3): 211-222. PMID25518052. doi:10.1093/ecco-jcc/jju009.Se sugiere usar |número-autores= (ayuda)
Chertow, Glenn M.; Mason, Phillip D.; Vaage-Nilsen, Odd; Ahlmén, Jarl (2004). «On the relative safety of parenteral iron formulations». Nephrology Dialysis Transplantation19 (6): 1571-5. PMID15150356. doi:10.1093/ndt/gfh185.
Jahn, Markus R.; Andreasen, Hans B.; Fütterer, Sören; Nawroth, Thomas; Schünemann, Volker; Kolb, Ute; Hofmeister, Wolfgang; Muñoz, Manuel et al. (2011). «A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications». European Journal of Pharmaceutics and Biopharmaceutics78 (3): 480-91. PMID21439379. doi:10.1016/j.ejpb.2011.03.016.Se sugiere usar |número-autores= (ayuda)
web.archive.org
«Iron Preparations, Oral». The American Society of Health-System Pharmacists. Archivado desde el original el 22 de mayo de 2016. Consultado el 8 de enero de 2017.